Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 401–500 of 1,035
Adipose Tissue and Inflammatory Bowel Disease Pathogenesis
Fink, C., Karagiannides, I., Bakirtzi, K., & Pothoulakis, C. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22893 · Cited by 138
“BMI is more closely correlated with the development of metabolic syndrome.(24,25) The involvement of intraabdominal adipose tissue in metabolic syndrome development correlates well with elevations in cytokine levels observed in”
BackgroundHypogonadism and metabolic syndrome.
(2011) · PubMed · doi:10.3275/7806 · Cited by 125
Denzer, C., Thiere, D., Muche, R., Köenig, W., Mayer, H. G., Kratzer, W., & Wabitsch, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1125 · Cited by 138
Neutrophils Actively Contribute to Obesity-Associated Inflammation and Pathological Complications
Uribe‐Querol, E., & Rosales, C. (2022) · Cells · doi:10.3390/cells11121883 · Cited by 134
“Visceral adipose tissue is of particular interest because accumulation of fat in this tissue correlates with the development of the metabolic syndrome [75].”
BackgroundOkuno, Y., Fukuhara, A., Hashimoto, E., Kobayashi, H., Kobayashi, S., Otsuki, M., & Shimomura, I. (2018) · Diabetes · doi:10.2337/db17-1032 · Cited by 124
“This finding is important, because expansion of mesenteric WAT is clinically more correlated with metabolic syndrome (46).”
BackgroundChen, J., Li, L., Li, Y., Liang, X., Sun, Q., Yu, H., Zhong, J., Ni, Y., Chen, J., Zhao, Z., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0183-6 · Cited by 133
“cardiovascular disease and hypertension [4-6].”
Man, R. E. K., Sabanayagam, C., Chiang, P. P.-C., Li, L., Noonan, J. E., Wang, J. J., Wong, T. Y., Cheung, C. M. G., Tan, G. S. W., & Lamoureux, E. L. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.5103 · Cited by 132
Metabolic Stress in the Transition Period of Dairy Cows: Focusing on the Prepartum Period
Pascottini, O. B., Leroy, J., & OPSOMER, G. (2020) · Animals · doi:10.3390/ani10081419 · Cited by 124
Stocks, T., Lukanova, A., Bjørge, T., Ulmer, H., Manjer, J., Almquist, M., Concin, H., Engeland, A., Hallmans, G., Nagel, G., et al. (2010) · Cancer · doi:10.1002/cncr.25772 · Cited by 127
“However, the use of BMI as a measure of obesity is hampered by the finding that BMI is not a specific measure of abdominal fat mass, which is linked to metabolic aberrations, such as insulin resistance.(27) High BMI and high abdominal obesity, assessed as the waist circumference or as the waist-to-hip ratio, have been…”
BackgroundLow Levels of Androgens in Men with Erectile Dysfunction and Obesity
Corona, G., Mannucci, E., Fisher, A. D., Lotti, F., Petrone, L., Balercia, G., Bandini, E., Forti, G., & Maggi, M. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00856.x · Cited by 124
Murdolo, G., Piroddi, M., Luchetti, F., Tortoioli, C., Canonico, B., Zerbinati, C., Galli, F., & Iuliano, L. (2012) · Biochimie · doi:10.1016/j.biochi.2012.12.014 · Cited by 141
Arsenault, B. J., Rana, J. S., Lemieux, I., Després, J., Kastelein, J. J. P., Boekholdt, S. M., Wareham, N. J., & Khaw, K. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.229 · Cited by 139
Self-citationInsulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
Herman, M. E., O’Keefe, J. H., Bell, D. S. H., & Schwartz, S. S. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.09.001 · Cited by 130
Patients with Bardet-Biedl Syndrome Have Hyperleptinemia Suggestive of Leptin Resistance
Feuillan, P. P., Ng, D., Han, J. C., Sapp, J. C., Wetsch, K., Spaulding, E., Zheng, Y. C., Caruso, R. C., Brooks, B. P., Johnston, J. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2290 · Cited by 119
“Consistent with the increased visceral fat is our observation of elevation of triglycerides and diastolic blood pressure compared with obese controls (37).”
BackgroundMartin-Calvo, N., Moreno-Galarraga, L., & Martinez-Gonzalez, M. (2016) · Nutrients · doi:10.3390/nu8080512 · Cited by 122
“Several studies have suggested that WC and WtHr may be convenient to assess obesity because they correlate better than other indices with visceral abdominal fat [18], which is considered as the most dyslipidemic and most atherogenic manifestation of adiposity [19], and with metabolic risk factors in children [20,21].”
BackgroundFang, L., Guo, F., Zhou, L., Stahl, R. D., & Grams, J. M. (2015) · Adipocyte · doi:10.1080/21623945.2015.1034920 · Cited by 129
“It is associated with an increased risk of type 2 diabetes mellitus, metabolic syndrome, cardiovascular disease, and cancer.(2-6) The mechanism by which obesity promotes dysmetabolism is not fully understood, but the literature implicates adipose tissue itself in the pathophysiology.”
BackgroundAbdominal obesity: The cholesterol of the 21st century?
Després, J., Arsenault, B. J., Côté, M., Cartier, A., & Lemieux, I. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)71043-2 · Cited by 146
Self-citationWang, C., Wang, C., & Wei, Y. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05625.x · Cited by 119
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
Marzo, V. D., Piscitelli, F., & Mechoulam, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_4 · Cited by 133
“This phenomenon, in view of the aforementioned prolipogenetic role of the endocannabinoid system in the adipose tissue, might eventually result in more and more fat being stored in the abdominal depots and less and less in the subcutaneous depots, with potential deleterious consequences on cardiometabolic risk factors…”
BackgroundClinical importance of epicardial adipose tissue
Nagy, E., Jermendy, A. L., Merkely, B., & Maurovich-Horvat, P. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.63259 · Cited by 121
“Insulin resistance syndrome with the dysfunction of the abdominal fat compartment plays an important role in the disease development [2, 3].”
BackgroundDieli‐Conwright, C. M., Wong, L., Waliany, S., Bernstein, L., Salehian, B., & Mortimer, J. E. (2016) · Cancer · doi:10.1002/cncr.30104 · Cited by 117
“Visceral adipose tissue has been proposed to promote the development of inflammation(37) and insulin resistance.(38,39) This could explain the increased insulin resistance observed in the population in the current study.”
Norris, G. H., Porter, C. M., Jiang, C., Millar, C. L., & Blesso, C. N. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.09.017 · Cited by 125
Velikonja, A., Lipoglavšek, L., Zorec, M., Orel, R., & Avguštin, G. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.11.002 · Cited by 128
Arsenault, B. J., Lemieux, I., Després, J., Gagnon, P., Wareham, N. J., Stroes, E. S. G., Kastelein, J. J. P., Khaw, K., & Boekholdt, S. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.044 · Cited by 137
“By analogy, ndividuals with abdominal obesity characterized by a prepondernce of small, dense low-density lipoproteins (LDL) [4,5] have been hown to be at increased risk for CHD risk independently from”
BackgroundSelf-citationSadr-Azodi, O., Orsini, N., Andrén-Sandberg, Å., & Wolk, A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.381 · Cited by 123
Fat maintenance is a predictor of the murine lifespan response to dietary restriction
Liao, C., Rikke, B. A., Johnson, T. E., Gelfond, J. A. L., Diaz, V., & Nelson, J. F. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00702.x · Cited by 120
“The case favoring a role for reduced fat is based on the role of excess visceral adiposity in insulin resistance, type II diabetes, and metabolic syndrome (Despres & Lemieux, 2006).”
BackgroundIncreased Glucose Uptake in Visceral Versus Subcutaneous Adipose Tissue Revealed by PET Imaging
Christen, T., Sheikine, Y., Rocha, V. Z., Hurwitz, S., Goldfine, A. B., Di Carli, M., & Libby, P. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.06.004 · Cited by 120
“(3) We drew regions of interest on several slices and combin to obtain a volume of interest (VOI).”
Ambient Air Pollution: An Emerging Risk Factor for Diabetes Mellitus
Rao, X., Montresor-López, J., Puett, R. C., Rajagopalan, S., & Brook, R. D. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0603-8 · Cited by 129
Scott, E. J., Daley, A., Doll, H., Woodroofe, M. N., Coleman, R., Mutrie, N., Crank, H., Powers, H. J., & Saxton, J. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0104-x · Cited by 137
“Central adiposity is linked to elevated leptin concentration [43] and insulin resistance syndrome, including low-grade systemic inflammation [9], which is associated with cardiovascular morbidity/mortality in women [44], postmenopausal breast cancer risk [45, 46], and poorer survival in early-stage breast cancer patie…”
BackgroundPeng, H., Pan, L., Ran, S., Wang, M., Huang, S., Zhao, M., Cao, Z., Yao, Z., Xu, L., Yang, Q., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083032 · Cited by 127
“For a specific BMI, a large WC meant two-to three-fold of the risk of developing diabetes and cardiovascular disease (CVD) in the future (41).”
BackgroundInfluence of Age on the Association Between Various Measures of Obesity and All‐Cause Mortality
Kuk, J. L., & Ardern, C. I. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02486.x · Cited by 116
Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects
Yamakado, M., Tanaka, T., Nagao, K., Ishizaka, Y., Mitushima, T., Tani, M., Toda, A., Toda, E., Okada, M., Miyano, H., et al. (2012) · Clinical Obesity · doi:10.1111/j.1758-8111.2012.00039.x · Cited by 128
“Visceral fat tissue, rather than subcutaneous fat tissue, secretes tumour necrosis factor-a, interleukin-6 and other adipokines that strongly correlate with the development of metabolic complications (2,3) and with the occurrence of cardiovascular disease (2,3).”
BackgroundInfluentialChoi, B. S.-Y., Daniel, N., Houde, V. P., Ouellette, A., Marcotte, B., Varin, T. V., Vors, C., Feutry, P., Ilkayeva, O., Ståhlman, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23782-w · Cited by 126
“This is problematic for two important reasons: (1) casein does not have the same composition as the plant and animal sources of proteins that are abundant in most human diets, and (2) casein may reduce body weight gain as compared to other protein sources, especially in its hydrolyzed form3,4.”
BackgroundMethodEarly development of the metabolic syndrome after chemotherapy for testicular cancer
de Haas, E. C., Altena, R., Boezen, H. M., Zwart, N., Smit, A. J., Bakker, S. J. L., van Roon, A. M., Postma, A., Wolffenbuttel, B. H. R., Hoekstra, H. J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds527 · Cited by 113
“In addition, visceral adipose tissue produces proinflammatory and prothrombotic factors [6, 7].”
BackgroundAdipose tissue estrogen production and metabolism in premenopausal women
Hetemäki, N., Mikkola, T. S., Tikkanen, M. J., Wang, F., Hämäläinen, E., Turpeinen, U., Haanpää, M., Vihma, V., & Savolainen-Peltonen, H. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105849 · Cited by 118
“and adipokine profile, and therefore poses the greatest cardiometabolic risk [10,11].”
Busetto, L., Dixon, J., De Luca, M., Shikora, S., Pories, W., & Angrisani, L. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1214-1 · Cited by 118
“Similar findings have been already reported in obese individuals, where obese subjects with a disproportionate accumulation of visceral fat had increased incidence of metabolic disorders [90, 91].”
ResultMoreno‐Indias, I., & Tinahones, F. J. (2015) · Journal of Diabetes Research · doi:10.1155/2015/970375 · Cited by 135
Koenen, T. B., Stienstra, R., van Tits, L. J., Joosten, L. A. B., van Velzen, J. F., Hijmans, A., Pol, J. A., van der Vliet, J. A., Netea, M. G., Tack, C. J., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1480 · Cited by 115
“The enhanced rate of lipolysis and resistance to insulin action in VAT (45, 46) may contribute to elevated activity levels of caspase-1.”
BackgroundDâmaso, A. R., Campos, R. M. D. S., Caranti, D. A., de Piano, A., Fisberg, M., Foschini, D., Sanches, P. D. L., Tock, L., Lederman, H. M., Tufik, S., et al. (2014) · Journal of Sports Sciences · doi:10.1080/02640414.2014.900692 · Cited by 111
“Lifestyle interventions, including various combinations of diet, exercise and education programmes, have been shown to reduce obesity and its comorbidities (Davis et al., 2009; Després & Lemieux, 2006).”
BackgroundSun, A. R., Panchal, S. K., Friis, T., Sekar, S., Crawford, R., Brown, L., Xiao, Y., & Prasadam, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183693 · Cited by 129
Sharma, A., Vallakati, A., Einstein, A. J., Lavie, C. J., Arbab‐Zadeh, A., López-Jiménez, F. A., Mukherjee, D., & Lichstein, E. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.04.020 · Cited by 126
Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis
Crudele, L., Piccinin, E., & Moschetta, A. (2021) · Nutrients · doi:10.3390/nu13062101 · Cited by 129
“Furthermore, the metabolic syndrome [31], a well-known obesity associated condition [32], increases the risk of developing [33] and having relapse in colorectal cancer [34,35].”
BackgroundEffects of caloric restriction on the gut microbiome are linked with immune senescence
Sbierski‐Kind, J., Grenkowitz, S., Schlickeiser, S., Sandforth, A., Friedrich, M., Kunkel, D., Glauben, R., Brachs, S., Mai, K., Thürmer, A., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01249-4 · Cited by 121
Hanley, A. J. G., Wagenknecht, L. E., Norris, J. M., Bryer-Ash, M., Chen, Y. I., Anderson, A. M., Bergman, R., & Haffner, S. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1464-y · Cited by 115
“adipose tissue in these individuals [5, 6].”
Gaborit, B., Kober, F., Jacquier, A., Moro, P. J., Cuisset, T., Boullu, S., Dadoun, F., Alessi, M.-C., Morange, P., Clément, K., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.117 · Cited by 116
Davaatseren, M., Hur, H. J., Yang, H. J., Hwang, J., Park, J. H., Kim, H., Kim, M. J., Kwon, D. Y., & Sung, M. J. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.04.023 · Cited by 126
“conditions of both NAFLD and obesity because they involve lipid accumulation (steatosis), formation of lipid accumulation, and inflammation (hepatitis) in the liver due to dysfunction of adipose, liver, and muscle tissues and resultant imbalance of lipid metabolism (Polyzos et al., 2009; Després and Lemieux, 2006).”
BackgroundEarly Life Nutritional Programming of Obesity: Mother-Child Cohort Studies
Symonds, M. E., Méndez, M. A., Meltzer, H. M., Koletzko, B. V., Godfrey, K. M., Forsyth, S. J., & van der Beek, E. M. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000345598 · Cited by 130
Corona, G., Mannucci, E., Petrone, L., Balercia, G., Paggi, F., Fisher, A. D., Lotti, F., Chiarini, V., Fedele, D., Forti, G., et al. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00529.x · Cited by 117
Adipose tissue, diet and aging
Zamboni, M. M., Rossi, A. P., Fantin, F., Zamboni, G. A., Chirumbolo, S., Zoico, E., & Mazzali, G. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.008 · Cited by 135
“…dys-regulation of lipid metabolism in subcutaneous adipocytes could in part explain not only the increases in visceral adiposity but also fat deposition within non-adipose tissues such as the skeletal and cardiac muscle, liver and pancreas (Després and Lemieux, 2006; Rossi et al., 2011) (Fig.”
BackgroundMagnussen, C. G., Koskinen, J. M., Juonala, M., Chen, W., Srinivasan, S. R., Sabin, M. A., Thomson, R. J., Schmidt, M. D., Nguyen, Q. M., Xu, J.-H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.056 · Cited by 128
“tance of the diagnosis above and beyond identification and treatment of its component parts, however, is controversial in children and adolescents (herein termed youth) (2,3) as well as adults (4,5).”
BackgroundKnight, S. F., Quigley, J. E., Yuan, J., Roy, S., Elmarakby, A. A., & Imig, J. D. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.099499 · Cited by 124
A physiological characterization of the Cafeteria diet model of metabolic syndrome in the rat
Gomez-Smith, M., Karthikeyan, S., Jeffers, M. S., Janik, R., Thomason, L. A. M., Stefanovic, B., & Corbett, D. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.09.029 · Cited by 129
Wassenaar, P. N. H., Trasande, L., & Legler, J. (2017) · Environmental Health Perspectives · doi:10.1289/ehp1233 · Cited by 122
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170009 · Cited by 86
“Interestingly, the amount of visceral fat has been shown repeatedly to be among the most critical determinants of the presence of the clustering metabolic syndrome features in men as well as women (75,246).”
Metabolic and Epigenetic Regulation by Estrogen in Adipocytes
Bjune, J.-I., Panahandeh, P., Jersin, R. Å., Mellgren, G., & Dankel, S. N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.828780 · Cited by 122
Impaired Wound Healing Predisposes Obese Mice to Severe Influenza Virus Infection
O’Brien, K. B., Vogel, P., Duan, S., Govorkova, E. A., Webby, R. J., McCullers, J. A., & Schultz-Cherry, S. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir729 · Cited by 113
“documented [12–14], the past decade has highlighted”
Thomas, E. L., Parkinson, J. R. C., Hyde, M. J., Yap, I. K. S., Holmes, E. C., Doré, C. J., Bell, J. D., & Modi, N. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e31822d7860 · Cited by 123
C‐reactive protein, obesity, and the risk of arterial and venous thrombosis
Horvei, L. D., Grimnes, G., Hindberg, K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Brox, J. H., Brækkan, S. K., & Hansen, J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13369 · Cited by 118
López-Jiménez, F. A., & Cortés-Bergoderi, M. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.10.010 · Cited by 181
“The fact that there are various ways of measuring abdominal circumference is also a source of inconsistency.(12)”
Gustafson, B., & Smith, U. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.812 · Cited by 129
Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine
Park, H.-L., Shim, S.-H., Lee, E.-Y., Cho, W., Park, S., Jeon, H.-J., Ahn, S.-Y., Kim, H., & Nam, J.-H. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28332 · Cited by 113
“Obesity is a metabolic disorder characterized by the accumulation of excessive body fat and low-grade chronic inflammation.(8) Obesity has become a major health concern in many countries.”
BackgroundSvare, A., Nilsen, T. I. L., Bjøro, T., Åsvold, B. O., & Langhammer, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04009.x · Cited by 113
Lee, Y., Choi, H., Seo, M.-J., Jeon, H., Kim, K., & Lee, B.-Y. (2015) · Food & Function · doi:10.1039/c5fo00481k · Cited by 113
Marín, L., Gutiérrez‐del‐Río, I., Yagüe, P., Manteca, Á., Villar, C. J., & Lombó, F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00921 · Cited by 117
Adipose tissue as a key player in obstructive sleep apnoea
Ryan, S., Arnaud, C., Fitzpatrick, S. F., Gaucher, J., Tamisier, R., & Pépin, J. (2019) · European Respiratory Review · doi:10.1183/16000617.0006-2019 · Cited by 120
Parvaresh, A., Razavi, R., Abbasi, B., Yaghoobloo, K., Hassanzadeh, A., Mohammadifard, N., Safavi, S. M., Hadi, A., & Clark, C. C. T. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.08.021 · Cited by 105
Culture of Isolated Human Adipocytes and Isolated Adipose Tissue
Carswell, K. A., Lee, M., & Fried, S. K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-367-7_14 · Cited by 113
Stefan, N., Häring, H., Hu, F. B., & Schulze, M. B. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00474-x · Cited by 117
Long noncoding RNAs in regulating adipogenesis: new RNAs shed lights on obesity
Wei, S., Du, ., Jiang, Z., Hausman, G. J., Zhang, L., & Dodson, M. V. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2169-2 · Cited by 116
Tanigaki, K., Sacharidou, A., Peng, J., Chambliss, K. L., Yuhanna, I. S., Ghosh, D., Ahmed, M., Szalai, A. J., Vongpatanasin, W., Mattrey, R. F., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89333 · Cited by 107
“There has been an alarming rise in the incidence of diabetes, with the number of adult diabetics globally rocketing from 108 million in 1980 to 422 million in 2014 (3), and the bulk of the increase involves obesity-induced insulin resistance and type 2 diabetes mellitus (T2DM) (4).”
BackgroundBroken Energy Homeostasis and Obesity Pathogenesis: The Surrounding Concepts
Ghanemi, A., Yoshioka, M., & St-Amand, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110453 · Cited by 107
“Metabolic syndrome [41] could be seen as the most significant manifestation of these metabolic disorders, where systems and tissues become metabolically unhealthy, with insulin signaling being at the center of the syndrome [7].”
BackgroundSerum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
Møller, H. J., Frikke-Schmidt, R., Moestrup, S. K., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.154724 · Cited by 109
Wiedmer, P., Nogueiras, R., Broglio, F., D'Alessio, D., & Tschöp, M. H. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0625 · Cited by 111
“Many of these physiologic processes are affected by obesity, insulin resistance, impaired glucose tolerance and type 2 diabetes as well as by atherosclerosis and dyslipidemia”
BackgroundPetta, S., Amato, M., Cabibi, D., Cammà, C., Di Marco, V., Giordano, C., Galluzzo, A., & Craxì, A. (2010) · Hepatology · doi:10.1002/hep.23859 · Cited by 108
“Recent studies have shown that visceral adipose tissue, originally considered a passive depot for energy storage, secretes a variety of substances that regulate metabolism, inflammation, and immunity, in turn participating in the pathogenesis of cardiovascular disease, IR, and diabetes.(8,9) In addition, visceral adip…”
BackgroundNg, K., Ghoting, A., Steinhubl, S. R., Stewart, W. F., Malin, B., & Sun, J. (2014) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2013.12.012 · Cited by 110
“For example, it is known that obesity, with or without the metabolic syndrome, increases an individual’s risk for developing diabetes [5], yet the majority of these individuals do not develop diabetes.”
BackgroundEarly Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents
Klaver, M., de Mutsert, R., Wiepjes, C. M., Twisk, J. W. R., den Heijer, M., Rotteveel, J., & Klink, D. T. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.12.009 · Cited by 129
Hu, W., Fitzgerald, M. A., Topp, B. L., Alam, M. M., & O’Hare, T. J. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103520 · Cited by 121
Flynn, K., Mahmoud, N. N., Sharifi, S., Gould, L. J., & Mahmoudi, M. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00030 · Cited by 119
Beneficial Impact of Exercise and Obesity Interventions on Erectile Function and its Risk Factors
Hannan, J. L., Maio, M. T., Komolova, M., & Adams, M. A. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01143.x · Cited by 112
Obesity and asthma: beyond TH2 inflammation
Leiria, L. O., Martins, M. A., & Saad, M. J. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.002 · Cited by 120
“of insulin resistance and diabetes [67,68].”
Cheung, L. P., Ma, R. C. W., Lam, P. M., Lok, I. H., Haines, C. J., So, W. Y., Tong, P. C. Y., Cockram, C. S., Chow, C. C., & Goggins, W. B. (2008) · Human Reproduction · doi:10.1093/humrep/den090 · Cited by 108
Nöthlings, U., Murphy, S. P., Wilkens, L. R., Henderson, B. E., & Kolonel, L. N. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1495 · Cited by 118
“hypothesis of a different association by overweight or obesity that can be associated with insulin resistance (26, 33, 34), we also calculated all models separately for normal-weight (BMI 25) or overweight or obese (BMI 25) participants.”
MethodCastration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice
Harada, N., Hanaoka, R., Horiuchi, H., Kitakaze, T., Mitani, T., Inui, H., & Yamaji, R. (2016) · Scientific Reports · doi:10.1038/srep23001 · Cited by 110
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
Palomer, X., Barroso, E., Pizarro‐Delgado, J., Peña, L., Botteri, G., Zarei, M., Aguilar-Recarte, D., Montori-Grau, M., & Vázquez‐Carrera, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030913 · Cited by 118
“Expansion of the visceral adipose tissue, which is considered a dysfunctional adipose tissue unable to store excessive levels of lipids, to a greater extent than that of subcutaneous adipose tissue, is associated with metabolic alterations [6].”
BackgroundReview article: obesity and colorectal cancer
Bardou, M., Rouland, A., Martel, M., Loffroy, R., Barkun, A. N., & Chapelle, N. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17045 · Cited by 119
Kuzawa, C. W., Hallal, P. C., Adair, L., Bhargava, S. K., Fall, C. H. D., Lee, N., Norris, S. A., Osmond, C., Ramirez‐zea, M., Sachdev, H. S., et al. (2012) · American Journal of Human Biology · doi:10.1002/ajhb.21227 · Cited by 106
“Although our focus here has been on body composition per se, future work should also evaluate associations with regional fat patterning, as this may be an important link between early growth processes and the metabolic syndrome and cardiovascular disease risk (Despres and Lemieux, 2006).”
BackgroundAnti-inflammatory activity of mulberry leaf extract through inhibition of NF-κB
Park, E., Lee, S.-M., Lee, J. E., & Kim, J. (2012) · Journal of Functional Foods · doi:10.1016/j.jff.2012.10.002 · Cited by 110
Gorgey, A. S., Mather, K. J., & Gater, D. R. (2010) · Metabolism · doi:10.1016/j.metabol.2010.08.002 · Cited by 116
“In able-bodied and other clinical populations, an increase in VAT is associated with glucose intolerance and insulin resistance, supporting the notion that VAT may play an important role in the pathogenesis of impaired carbohydrate metabolism [12-16].”
BackgroundMethodResultInfluentialThe correlation between pancreatic steatosis and metabolic syndrome in a Chinese population
Zhou, J., Li, M., Zhang, D., Lin, H., Dai, X., Sun, X., Li, J., Song, L., Peng, H., & Wen, M.-M. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.008 · Cited by 110
“Central obesity per se is one of the clinical intermediate phenotypes of ectopic fat deposition [3].”
BackgroundRapid Postnatal Weight Gain and Visceral Adiposity in Adulthood: The Fels Longitudinal Study
Demerath, E. W., Reed, D., Choh, A. C., Soloway, L. E., Lee, M., Czerwinski, S. A., Chumlea, W. C., Siervogel, R. M., & Towne, B. (2009) · Obesity · doi:10.1038/oby.2009.105 · Cited by 119
“Body fat centralization involves a heterogeneous set of tissue types, including both abdominal visceral adipose tissue (VAT) and abdominal subcutaneous adipose tissue (ASAT), which have distinguishable effects on the metabolic syndrome and diabetes risk (13–16), circulating adipokine levels (15,17,18), and possibly mo…”
BackgroundObesity results in adipose tissue T cell exhaustion
Porsche, C. E., Delproposto, J. B., Geletka, L., O’Rourke, R., & Lumeng, C. N. (2021) · JCI Insight · doi:10.1172/jci.insight.139793 · Cited by 96
“Obesity-associated morbidities such as type II diabetes are characterized by insulin resistance, which is mechanistically linked to adipose tissue dysfunction and inflammation (1-3).”
BackgroundYue, Y., Li, P., Sun, Z., Murayama, R., Li, Z., Hashimoto, K., & Zhang, Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02854-x · Cited by 117
“Visceral adipose tissue exacerbates these processes by secreting proinflammatory cytokines (e.g., TNF-α, IL-6) and free fatty acids, which interfere with insulin signaling, fuel systemic inflammation, and promote macro-phage-mediated vascular damage [63].”
Uemura, Y., Shibata, R., Ohashi, K., Enomoto, T., Kambara, T., Yamamoto, T., Ogura, Y., Yuasa, D., Joki, Y., Matsuo, K., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-213744 · Cited by 109
The Association of Metabolic Syndrome and Urolithiasis
Wong, Y. V., Cook, P. R., & Somani, B. K. (2015) · International Journal of Endocrinology · doi:10.1155/2015/570674 · Cited by 118
Huang, C.-W., Chien, Y.-S., Chen, Y.-J., Ajuwon, K., Mersmann, H., & Ding, S.-T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101689 · Cited by 100
Mi, Y., Yan, S., Lu, Y., Liang, Y., & Li, C. (2016) · Medicine · doi:10.1097/md.0000000000004495 · Cited by 101
Leisure-time physical activity and high-risk fat: a longitudinal population-based twin study
Leskinen, T., Sipilä, S., Alen, M., Cheng, S., Pietiläinen, K. H., Usenius, J.-P., Suominen, H., Kovanen, V, Kainulainen, H., Kaprio, J., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.170 · Cited by 107
Obesity and risk of sepsis: A population‐based cohort study
Wang, H. E., Griffin, R., Judd, S., Shapiro, N. I., & Safford, M. M. (2013) · Obesity · doi:10.1002/oby.20468 · Cited by 107
“CRP levels also appear to be elevated in individuals with abdominal obesity; we have previously found that elevated high sensitivity CRP is associated with sepsis risk (34,35).”
BackgroundDing, J., Reynolds, L. M., Zeller, T., Müller, C., Lohman, K., Nicklas, B. J., Kritchevsky, S. B., Huang, Z., de la Fuente, A., Soranzo, N., et al. (2015) · Diabetes · doi:10.2337/db14-1314 · Cited by 112
“However, our data showed that the BMI associations were similar to the associations with waist circumference, a surrogate of visceral adiposity (46).”
ResultChen, H., Chen, X., Zhang, W., Yang, K., Chen, X., Zhang, B., Chen, Z., Chen, J.-P., Zhou, Z., & Hu, J. (2015) · Medicine · doi:10.1097/md.0000000000001769 · Cited by 115
“and metabolic responses, resulting in several specific diseases known collectively as metabolic syndrome.(23) Additionally, excess adipose tissue may extend the operative time, cause”
Background
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.